en · de · es · pt
epitalon-notes.peptides7250.com › Blog › Origin And Telomerase Research Claims — Complete Guide

Origin And Telomerase Research Claims — Complete Guide

By Editorial Desk · published 2026-01-28 · last reviewed 2026-02-18 · Blog

HPLC purity is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.

Last reviewed on 2026-02-18. Where a claim depends on a specific study, the study is described rather than over-claimed.

Origin and Telomerase Research Claims

Epitalon emerged from research conducted in Saint Petersburg by Vladimir Khavinson and colleagues, who studied short peptides as potential regulators of aging. The work built on epithalamin, a pineal gland extract reported to influence neuroendocrine function. Epitalon was designed as a synthetic counterpart with a defined sequence, allowing reproducible experiments that extracts could not support. Early publications described effects on melatonin rhythms and lifespan in animal models. These findings circulated mainly in Russian-language journals during the 1990s, which limited their visibility among English-speaking researchers.

The most widely cited claim is that epitalon activates telomerase and thereby extends telomere length. Supporting evidence comes largely from cultured human cells, where treatment was associated with increased telomerase activity and delayed replicative senescence. Telomerase activation is a biologically consequential effect, since the enzyme is largely silenced in most somatic cells. However, the route by which a short peptide would reach and act on the enzyme's regulatory machinery has not been established. Independent replication in human trials is scarce, so the link between cell-culture observations and whole-body aging remains an open question.

Human data are limited to small studies, often without the randomization, blinding, or control groups expected in contemporary clinical research. Reported outcomes have included changes in melatonin levels, immune markers, and subjective measures, but sample sizes were generally too small to support firm conclusions. Some reviews treat the peptide as promising while noting methodological weaknesses; others question whether the observed effects are specific. The compound is frequently discussed in longevity-focused communities, where enthusiasm often outpaces the published evidence. Separating established findings from speculation is therefore important when reading summaries of this research.

Peptide Identity and Laboratory Handling

Laboratory-grade epitalon is typically supplied as a lyophilized powder. Purity is commonly assessed with reverse-phase high-performance liquid chromatography, often paired with mass spectrometry to confirm molecular identity. Amino acid analysis and peptide mapping can provide additional confirmation of sequence. Certificates of analysis for research materials frequently report purity above 95 percent, although the methods behind such figures vary between suppliers. The absence of a pharmacopeial monograph means that no single standardized assay defines the compound, so reported results depend on the analytical protocol chosen.

Storage recommendations center on limiting moisture, heat, and light. The dry powder is generally kept at minus 20 degrees Celsius, and some suppliers recommend minus 80 degrees for long-term archival. Once dissolved, solutions are usually aliquoted and frozen to avoid repeated freeze-thaw cycles, which can promote aggregation or degradation. Aqueous stability depends on pH and concentration, and buffered saline is often preferred over plain water for biological work. Stability data specific to epitalon remain limited, so general peptide-handling practices are applied by analogy rather than from product-specific validation.

Epitalon is a synthetic tetrapeptide with the sequence alanine-glutamate-aspartate-glycine, abbreviated AEDG. Its molecular formula is C14H22N4O9 and its calculated monoisotopic mass is approximately 390.35 daltons. The compound does not occur naturally as a free peptide; it is produced by solid-phase peptide synthesis. Because it contains two acidic residues and no basic residues, the neutral form carries a net negative charge at physiological pH. This charge profile influences how the peptide behaves in solution and during chromatographic analysis.

Epitalon at a glance

PropertyValueNotes
Peptide sequenceAla-Glu-Asp-GlySingle-letter form AEDG
Compound classSynthetic tetrapeptideNot a natural free peptide
Research originRussian gerontology institutesDeveloped during the 1990s
Main research claimTelomerase activationEvidence mainly from cultured cells
Regulatory statusNot an approved drugHandled as a research material

Storage, Assay, and Regulatory Framework

Freeze-dried epitalon is normally kept at minus twenty degrees Celsius in a sealed, desiccated container, protected from light. Short excursions at ambient temperature during shipping are generally tolerated, but repeated warming and cooling cycles encourage moisture uptake, which shortens shelf life. Once dissolved, the peptide is far less stable than the solid: aqueous solutions are subject to hydrolysis and to deamidation at the aspartate and glutamate residues. Working solutions are therefore held refrigerated and used within days, and repeated freezing and thawing of the same vial is best avoided.

Identity and purity are checked by reversed-phase high-performance liquid chromatography, usually with ultraviolet detection near 214 nanometres, where the peptide bond absorbs. Mass spectrometry confirms the expected mass and reveals whether truncation products or adducts are present. Acid hydrolysis followed by amino acid analysis gives the residue ratio, which should approximate one alanine, one glutamate, one aspartate and one glycine. Counter-ions such as acetate or trifluoroacetate remain in the dried product and lower net peptide content, so a stated purity figure on a label does not by itself describe how much peptide a vial holds.

Regulatory treatment differs by country. No formulation of epitalon holds a marketing authorisation as a medicine in the United States or the European Union, where material sold for laboratory use is handled as a research chemical and is not intended for human consumption. In Russia, several short peptide preparations from the same institute's peptide series are registered medicinal products, and epitalon appears in that national context. Elsewhere it is frequently offered as a cosmetic ingredient, a category with lighter requirements. Advertising claims about longevity or disease prevention are restricted in most jurisdictions, which limits how sellers describe the compound.

Related pages on this site

Background and Proposed Mechanism

The most frequently cited proposed action is induction of telomerase, the enzyme that adds repeat sequences to chromosome ends. Cell-culture work from the originating group reported higher telomerase reverse transcriptase expression and measurable telomere elongation in human somatic cells after exposure. How a four-residue peptide would reach nuclear gene regulation is not established, and no cell-surface receptor or uptake route has been identified. Additional reports describe changes in melatonin secretion, antioxidant enzyme activity and lipid peroxidation in aged animals, but these findings remain mechanistically unconnected to the telomerase observation.

Published evidence comes mainly from Russian-language journals and from a single research group, with small sample sizes and limited independent replication. A few laboratories outside that group have examined related peptides and reported weaker or absent telomerase effects, so the central claim is best described as contested rather than settled. Rodent studies report modest changes in some ageing markers and in survival, but designs vary and control conditions are often sparse. No large randomised trial in humans has been published, and long-term safety data in healthy populations are correspondingly thin.

Epitalon is a synthetic tetrapeptide with the sequence alanine-glutamate-aspartate-glycine, commonly abbreviated AEDG. It was designed at the St. Petersburg Institute of Bioregulation and Gerontology as a short, chemically defined analogue of epithalamin, a fraction obtained from bovine pineal tissue. Small peptide bioregulators of this type formed a long-running line of work there from the 1980s onward. Because the molecule is produced by solid-phase synthesis rather than extraction, its composition is exact and its purity can be measured directly.

Supporting material

== Preparation == A total synthesis of the coicenal family has not been conducted, but a method to prepare coicenal diterpenes for anti-inflammatory medicine was patented in 2013. There are minor differences between the synthetic analogs outlined in the patent and naturally occurring coicenals. The patent's synthesis procedure uses Bipolaris coicis as a starting material. Synthesis routes for coicenal A-C are presented, and each share the following similarities. First, a bacterial sample of Bipolaris coicis is fermented for 40 days at 28 °C. The fully fermented sample is then ultrasonicated and the resultant solution is collected. After rotary evaporation, this crude extract is purified via silica gel column chromatography. The yielded dry matter is then purified via gel permeation chromatography, followed by high-performance liquid chromatography. The final structure of the synthesized coisenals are then determined by proton nuclear magnetic resonance.

=== Factors found not to correlate with fibromyalgia === Studies on personality and fibromyalgia have shown inconsistent results. Although some have suggested that fibromyalgia patients are more likely to have specific personality traits, it appears that, in comparison to other diseases, when anxiety and depression are statistically controlled for, personality has less relevance, and does not differ from healthy controls.

== Research == There is no cure for any type of muscular dystrophy group. Several drugs designed to address the root cause are under development, including gene therapy (Microdystrophin), and antisense drugs (Ataluren, Eteplirsen etc.). Other medications used include corticosteroids (Deflazacort), calcium channel blockers (Diltiazem) to slow skeletal and cardiac muscle degeneration, anticonvulsants to control seizures and some muscle activity, and immunosuppressants (Vamorolone) to delay damage to dying muscle cells. Physical therapy, braces, and corrective surgery may help with some symptoms while assisted ventilation may be required in those with weakness of breathing muscles. Outcomes depend on the specific type of disorder.

=== Foreign relations === On 18 June 2013, he met with Fra’ Matthew Festing, the Prince and Grand Master of the Sovereign Military Order of Malta, where they talked about humanitarianism, Gnassingbé's efforts to improve Togo's humanitarian contributions in his presidency. In 2010, Prime Minister of Japan Yukio Hatoyama congratulated Gnassingbé for winning that year's presidential election. In 2023, Gnassingbé met Fumio Kishida in the Japan-Togo summit meeting where Kishida expressed his support for Gnassingbé for visiting the funeral of Shinzo Abe. In 2025, Gnassingbé was selected as a mediator by the African Union to replace Angolan president João Lourenço in resolving the conflict in the Democratic Republic of the Congo.

Sources: en.wikipedia.org

Supporting material

=== United States === In the United States, semaglutide is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes, and to reduce the risk of major adverse cardiovascular events in adults with type 2 diabetes and established cardiovascular disease. In combination with a reduced-calorie diet and increased physical activity, semaglutide (as Wegovy) is indicated to reduce the risk of major adverse cardiovascular events (cardiovascular death, non-fatal myocardial infarction, or non-fatal stroke) in adults with established cardiovascular disease and who are either obese or overweight; to reduce excess body weight and maintain weight reduction long term in obese individuals twelve years of age or older, or for overweight adults with at least one weight-related comorbid condition. In August 2025, the Food and Drug Administration (FDA) expanded the indication for semaglutide (as Wegovy) to include the treatment of noncirrhotic metabolic-associated steatohepatitis (MASH), formerly known as nonalcoholic steatohepatitis (NASH), with moderate to advanced liver fibrosis (consistent with stages F2 to F3 fibrosis) in adults. In October 2025, the FDA further expanded the indication for semaglutide (as Rybelsus) to reduce the risk of major adverse cardiovascular events (cardiovascular death, non-fatal myocardial infarction, or non-fatal stroke) in adults with type 2 diabetes who are at high risk for these events.

DNA vaccination generates an effective immune memory via the display of antigen-antibody complexes on follicular dendritic cells (FDC), which are potent B-cell stimulators. T-cells can be stimulated by similar, germinal centre dendritic cells. FDC are able to generate an immune memory because antibodies production "overlaps" long-term expression of antigen, allowing antigen-antibody immunocomplexes to form and be displayed by FDC.

A κ-opioid receptor agonist, or simply KOR agonist or kappa agonist, is a drug which acts as an agonist of the κ-opioid receptor (KOR), the target of the endogenous dynorphin peptides such as dynorphin A and one of several types of opioid receptors. They can variably produce hallucinogenic effects, pro-depressive and dysphoric effects, sedation, analgesic effects, antipruritic (anti-itch) effects, and anti-addictive effects, among others. Due to their various effects, KOR agonists are used for a variety of medical uses and for other purposes. Salvinorin A is a highly potent and selective KOR agonist and hallucinogen found in Salvia divinorum (diviner's sage) which has been used as an entheogen by the Mazatec people of Mexico and as a recreational drug elsewhere. The psychoactive and other effects of salvinorin A have been evaluated in clinical studies. The non-selective opioid receptor antagonist naltrexone blocks the effects of salvinorin A. Synthetic analogues with greater potency and/or duration include salvinorin B methoxymethyl ether (2-MMSB) and salvinorin B ethoxymethyl ether (2-EMSB). The irreversible G protein-biased agonist RB-64 (22-thiocyanatosalvinorin A) has unknown psychoactivity. Nalorphine (N-allylnormorphine; Lethidrone; Nalline) was an early opioid antagonist used to reverse opioid overdose which acts as a dual μ-opioid receptor (MOR) agonist–antagonist and KOR agonist and was superseded by other drugs like naloxone due to producing dysphoria and hallucinogenic effects among other drawbacks.

Sources: en.wikipedia.org

Notes from published material

Ronnie Kasrils, MK's intelligence chief, warned the Soviet mission that if Saluting October proceeded an SADF counteroffensive was imminent. Gusev overruled the Cuban and MK concerns, and the operation commenced without contingency plans for a South African intervention. The preliminary phase of the new offensive began in August 1987. Eight FAPLA brigades deployed to Tumpo, a region to the east of Cuito Cuanavale in early August, where on Soviet advice they temporarily paused for more supplies and reinforcements. This would prove to be a fatal error. On 14 August, having lost days of precious time, FAPLA resumed its efforts to advance; by then South Africa had launched Operation Moduler to halt the offensive. The bloody campaign that followed entailed a series of engagements known collectively as the Battle of Cuito Cuanavale.

=== 2025 parliamentary and regional elections === On 25 May 2025, Venezuela held elections for all 285 seats in the National Assembly, as well as most state governorships and regional legislatures. The ruling Great Patriotic Pole alliance led by the PSUV won nearly 83% of the vote for the Assembly and 23 of 24 state governorships, amid turnout of about 43% and a divided opposition in which some factions called for a boycott. Under the Constitution, deputies serve five-year terms, which implies that the following parliamentary election is due in 2030 unless early elections are called.

The behavior of NAPLs in the subsurface is guided by both the composition of the subsurface material and the various properties of the NAPLs. The subsurface can be categorized into two primary zones: the unsaturated (vadose) zone, which includes small grains or particles surrounded by a thin film of water; and the saturated (phreatic) zone, which contains important storages of groundwater called aquifers. NAPLs are point-source pollutants, and they can be released from a variety of sources, including, but not limited to, improper chemical disposal, leaking underground storage tanks, septic tank effluent, and percolation from spills or landfills. Under high precipitation conditions, liquid will infiltrate the unsaturated zone; if there is enough volume of liquid, it will then percolate into the saturated zone. The porosity of the subsurface environment will determine the quantity that manages to enter the saturated zone.

DNA nanoball sequencing is a type of high throughput sequencing technology used to determine the entire genomic sequence of an organism. The company Complete Genomics uses this technology to sequence samples submitted by independent researchers. The method uses rolling circle replication to amplify small fragments of genomic DNA into DNA nanoballs. Unchained sequencing by ligation is then used to determine the nucleotide sequence. This method of DNA sequencing allows large numbers of DNA nanoballs to be sequenced per run and at low reagent costs compared to other high-throughput sequencing platforms. However, only short sequences of DNA are determined from each DNA nanoball which makes mapping the short reads to a reference genome difficult.

Sources: en.wikipedia.org

Frequently asked questions

Who developed epitalon?

Vladimir Khavinson and colleagues at research institutes in Saint Petersburg developed and studied the peptide. Their program examined short peptides as regulators of aging and neuroendocrine function. Epitalon was one of several compounds produced by that group.

Does epitalon lengthen telomeres in humans?

That question is not settled. Cell culture studies have reported increased telomerase activity after treatment, but comparable evidence from controlled human trials is lacking. Any claim about telomere lengthening in people should be treated as unproven.

Why is epitalon not an approved medicine?

It has not completed the large, controlled trials required for drug approval in major jurisdictions. Most human reports involve small samples and limited follow-up. As a result, it is sold as a research chemical rather than a licensed pharmaceutical product.

What is epitalon made of?

Epitalon is a synthetic tetrapeptide built from four amino acids: alanine, glutamate, aspartate, and glycine. It is not extracted from a natural source but made in the laboratory by chemical synthesis. Its short length makes it relatively straightforward to produce at high purity.

Network